
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Spatial Heterogeneity in Drug Concentrations Can Facilitate the Emergence of Resistance to Cancer Therapy
Feng Fu, Martin A. Nowak, Sebastian Bonhoeffer
PLoS Computational Biology (2015) Vol. 11, Iss. 3, pp. e1004142-e1004142
Open Access | Times Cited: 132
Feng Fu, Martin A. Nowak, Sebastian Bonhoeffer
PLoS Computational Biology (2015) Vol. 11, Iss. 3, pp. e1004142-e1004142
Open Access | Times Cited: 132
Showing 1-25 of 132 citing articles:
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
Nicholas McGranahan, Charles Swanton
Cell (2017) Vol. 168, Iss. 4, pp. 613-628
Open Access | Times Cited: 2348
Nicholas McGranahan, Charles Swanton
Cell (2017) Vol. 168, Iss. 4, pp. 613-628
Open Access | Times Cited: 2348
The mathematics of cancer: integrating quantitative models
Philipp M. Altrock, Lin Liu, Franziska Michor
Nature reviews. Cancer (2015) Vol. 15, Iss. 12, pp. 730-745
Closed Access | Times Cited: 647
Philipp M. Altrock, Lin Liu, Franziska Michor
Nature reviews. Cancer (2015) Vol. 15, Iss. 12, pp. 730-745
Closed Access | Times Cited: 647
Clinical cancer nanomedicine
Joy Wolfram, Mauro Ferrari
Nano Today (2019) Vol. 25, pp. 85-98
Open Access | Times Cited: 381
Joy Wolfram, Mauro Ferrari
Nano Today (2019) Vol. 25, pp. 85-98
Open Access | Times Cited: 381
Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies
Jill Gallaher, Pedro M. Enríquez‐Navas, Kimberly A. Luddy, et al.
Cancer Research (2018) Vol. 78, Iss. 8, pp. 2127-2139
Open Access | Times Cited: 243
Jill Gallaher, Pedro M. Enríquez‐Navas, Kimberly A. Luddy, et al.
Cancer Research (2018) Vol. 78, Iss. 8, pp. 2127-2139
Open Access | Times Cited: 243
Computational oncology — mathematical modelling of drug regimens for precision medicine
Dominique Barbolosi, Joseph Ciccolini, Bruno Lacarelle, et al.
Nature Reviews Clinical Oncology (2015) Vol. 13, Iss. 4, pp. 242-254
Closed Access | Times Cited: 205
Dominique Barbolosi, Joseph Ciccolini, Bruno Lacarelle, et al.
Nature Reviews Clinical Oncology (2015) Vol. 13, Iss. 4, pp. 242-254
Closed Access | Times Cited: 205
Systemic therapy of brain metastases: non–small cell lung cancer, breast cancer, and melanoma
Marc C. Chamberlain, Christina Baik, Vijayakrishna K. Gadi, et al.
Neuro-Oncology (2016) Vol. 19, Iss. 1, pp. i1-i24
Open Access | Times Cited: 201
Marc C. Chamberlain, Christina Baik, Vijayakrishna K. Gadi, et al.
Neuro-Oncology (2016) Vol. 19, Iss. 1, pp. i1-i24
Open Access | Times Cited: 201
Hyperthermia and smart drug delivery systems for solid tumor therapy
Ann L.B. Seynhaeve, Mohamadreza Amin, Dieter Haemmerich, et al.
Advanced Drug Delivery Reviews (2020) Vol. 163-164, pp. 125-144
Open Access | Times Cited: 181
Ann L.B. Seynhaeve, Mohamadreza Amin, Dieter Haemmerich, et al.
Advanced Drug Delivery Reviews (2020) Vol. 163-164, pp. 125-144
Open Access | Times Cited: 181
Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance
Stefany Moreno-Gámez, Alison L. Hill, Daniel I. S. Rosenbloom, et al.
Proceedings of the National Academy of Sciences (2015) Vol. 112, Iss. 22
Open Access | Times Cited: 146
Stefany Moreno-Gámez, Alison L. Hill, Daniel I. S. Rosenbloom, et al.
Proceedings of the National Academy of Sciences (2015) Vol. 112, Iss. 22
Open Access | Times Cited: 146
Molecular and cellular bases of adaptation to a changing environment in microorganisms
Clara Bleuven, Christian R. Landry
Proceedings of the Royal Society B Biological Sciences (2016) Vol. 283, Iss. 1841, pp. 20161458-20161458
Open Access | Times Cited: 99
Clara Bleuven, Christian R. Landry
Proceedings of the Royal Society B Biological Sciences (2016) Vol. 283, Iss. 1841, pp. 20161458-20161458
Open Access | Times Cited: 99
Cell population heterogeneity and evolution towards drug resistance in cancer: Biological and mathematical assessment, theoretical treatment optimisation
Rebecca H. Chisholm, Tommaso Lorenzi, Jean Clairambault
Biochimica et Biophysica Acta (BBA) - General Subjects (2016) Vol. 1860, Iss. 11, pp. 2627-2645
Open Access | Times Cited: 90
Rebecca H. Chisholm, Tommaso Lorenzi, Jean Clairambault
Biochimica et Biophysica Acta (BBA) - General Subjects (2016) Vol. 1860, Iss. 11, pp. 2627-2645
Open Access | Times Cited: 90
Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer
Madhu Sharma, Avijit Kumar Bakshi, Naresh Mittapelly, et al.
Journal of Controlled Release (2022) Vol. 346, pp. 43-70
Closed Access | Times Cited: 46
Madhu Sharma, Avijit Kumar Bakshi, Naresh Mittapelly, et al.
Journal of Controlled Release (2022) Vol. 346, pp. 43-70
Closed Access | Times Cited: 46
Bacterial motility can govern the dynamics of antibiotic resistance evolution
Vit Piskovsky, Nuno M. Oliveira
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
Vit Piskovsky, Nuno M. Oliveira
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
Frequency-Dependent Ecological Interactions Increase the Prevalence, and Shape the Distribution, of Preexisting Drug Resistance
Jeff Maltas, Dagim Shiferaw Tadele, Arda Durmaz, et al.
PRX Life (2024) Vol. 2, Iss. 2
Open Access | Times Cited: 9
Jeff Maltas, Dagim Shiferaw Tadele, Arda Durmaz, et al.
PRX Life (2024) Vol. 2, Iss. 2
Open Access | Times Cited: 9
Biologically Relevant Heterogeneity: Metrics and Practical Insights
Albert Gough, Andrew M. Stern, John Maier, et al.
SLAS DISCOVERY (2017) Vol. 22, Iss. 3, pp. 213-237
Open Access | Times Cited: 81
Albert Gough, Andrew M. Stern, John Maier, et al.
SLAS DISCOVERY (2017) Vol. 22, Iss. 3, pp. 213-237
Open Access | Times Cited: 81
Mathematical Approach to Differentiate Spontaneous and Induced Evolution to Drug Resistance During Cancer Treatment
James M. Greene, Jana L. Gevertz, Eduardo D. Sontag
JCO Clinical Cancer Informatics (2019), Iss. 3, pp. 1-20
Open Access | Times Cited: 70
James M. Greene, Jana L. Gevertz, Eduardo D. Sontag
JCO Clinical Cancer Informatics (2019), Iss. 3, pp. 1-20
Open Access | Times Cited: 70
Combination Therapy and the Evolution of Resistance: The Theoretical Merits of Synergism and Antagonism in Cancer
Elysia C. Saputra, Lu Huang, Yihui Chen, et al.
Cancer Research (2018) Vol. 78, Iss. 9, pp. 2419-2431
Open Access | Times Cited: 68
Elysia C. Saputra, Lu Huang, Yihui Chen, et al.
Cancer Research (2018) Vol. 78, Iss. 9, pp. 2419-2431
Open Access | Times Cited: 68
Advanced technological tools to study multidrug resistance in cancer
Andrei Luca, Sandor Kasas, Ignacio Ochoa Garrido, et al.
Drug Resistance Updates (2019) Vol. 48, pp. 100658-100658
Open Access | Times Cited: 66
Andrei Luca, Sandor Kasas, Ignacio Ochoa Garrido, et al.
Drug Resistance Updates (2019) Vol. 48, pp. 100658-100658
Open Access | Times Cited: 66
Understanding patterns of HIV multi-drug resistance through models of temporal and spatial drug heterogeneity
Alison F. Feder, Kristin N. Harper, Chanson J. Brumme, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 44
Alison F. Feder, Kristin N. Harper, Chanson J. Brumme, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 44
The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
Sean Cavany, Stella Nanyonga, Cathrin Hauk, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Sean Cavany, Stella Nanyonga, Cathrin Hauk, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Sequential mutations in exponentially growing populations
Michael D. Nicholson, David Cheek, Tibor Antal
PLoS Computational Biology (2023) Vol. 19, Iss. 7, pp. e1011289-e1011289
Open Access | Times Cited: 21
Michael D. Nicholson, David Cheek, Tibor Antal
PLoS Computational Biology (2023) Vol. 19, Iss. 7, pp. e1011289-e1011289
Open Access | Times Cited: 21
Modeling of signaling crosstalk-mediated drug resistance and its implications on drug combination
Xiaoqiang Sun, Jiguang Bao, Zhu‐Hong You, et al.
Oncotarget (2016) Vol. 7, Iss. 39, pp. 63995-64006
Open Access | Times Cited: 51
Xiaoqiang Sun, Jiguang Bao, Zhu‐Hong You, et al.
Oncotarget (2016) Vol. 7, Iss. 39, pp. 63995-64006
Open Access | Times Cited: 51
Interplay of Darwinian Selection, Lamarckian Induction and Microvesicle Transfer on Drug Resistance in Cancer
Arturo Álvarez-Arenas, Ana Podolski-Renić, Juan Belmonte-Beitia, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 48
Arturo Álvarez-Arenas, Ana Podolski-Renić, Juan Belmonte-Beitia, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 48
Combinatorial nanocarriers against drug resistance in hematological cancers: Opportunities and emerging strategies
Saikat Ghosh, Rohan Lalani, Vivek Patel, et al.
Journal of Controlled Release (2019) Vol. 296, pp. 114-139
Closed Access | Times Cited: 43
Saikat Ghosh, Rohan Lalani, Vivek Patel, et al.
Journal of Controlled Release (2019) Vol. 296, pp. 114-139
Closed Access | Times Cited: 43
Spatial segregation and cooperation in radially expanding microbial colonies under antibiotic stress
Anupama Sharma, Kevin B. Wood
The ISME Journal (2021) Vol. 15, Iss. 10, pp. 3019-3033
Open Access | Times Cited: 33
Anupama Sharma, Kevin B. Wood
The ISME Journal (2021) Vol. 15, Iss. 10, pp. 3019-3033
Open Access | Times Cited: 33
Advancements in Preclinical Models of Pancreatic Cancer
P Salu, Katie M. Reindl
Pancreas (2024) Vol. 53, Iss. 2, pp. e205-e220
Closed Access | Times Cited: 5
P Salu, Katie M. Reindl
Pancreas (2024) Vol. 53, Iss. 2, pp. e205-e220
Closed Access | Times Cited: 5